Lv71
4868 积分 2021-12-01 加入
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
18天前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
24天前
已完结
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
1个月前
已完结
Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment
1个月前
已完结
Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide
1个月前
已完结
Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study
2个月前
已完结
A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection
2个月前
已完结
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
2个月前
已完结
How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
2个月前
已完结
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
2个月前
已完结
皖公网安备34019202002308
